|
7
|
|
Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer.
(linkinghub.elsevier.com)
|
Danieli-Mackay A
…
Papantonis A
Cell Reports
2026-08-24
|
#pancreatic cancer
#transcriptomics
#drug-targeting
#chromatin
|
|
2
|
|
Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactose.
(nature.com)
|
Chen Y
…
Dong L
Nature Cancer
2026-08-17
|
#microbiome
#immunotherapy
#pancreatic cancer
#metabolism
#macrophage
|
|
1
|
|
SPINK1-COL18A1 crosstalk shapes epigenome and drives cancer stemness in pancreatic ductal adenocarcinoma.
(linkinghub.elsevier.com)
|
Tang H
…
Ahuja N
Cell Reports
2026-08-18
|
#pancreatic cancer
#epigenomics
#cancer-stemness
#epigenetics
#signaling
|
|
1
|
|
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.
(nature.com)
|
Aronchik I
…
Singh M
Nature Medicine
2026-08-11
|
#amr
#pancreatic cancer
#targeted therapy
#kras
#circulating tumor dna
|
|
0
|
|
OGT-mediated O-GlcNAcylation of BICD2 drives gemcitabine resistance in pancreatic cancer via accelerating G2/M cell cycle progression.
(linkinghub.elsevier.com)
|
Liu L
…
Zhang Y
Drug Resistance Updates
2026-08-09
|
#pancreatic cancer
#drug resistance
#cell cycle
#ptm
#glycolysis
|
|
0
|
|
Stress granules confer an early vulnerability in KRAS-driven pancreatic tumorigenesis.
(linkinghub.elsevier.com)
|
Estaras M
…
Iovanna J
Cell Reports
2026-08-10
|
#pancreatic cancer
#stress response
#oncogenesis
#tumorigenesis
#kras
|
|
0
|
|
METTL1-mediated m7G modification of valine tRNAs drives metabolic adaptation in pancreatic ductal adenocarcinoma.
(jci.org)
|
Zhu J
…
Goel A
Journal of Clinical Investigation
2026-08-06
|
#translation
#pancreatic cancer
#metabolism
#trna-modifications
#methyltransferase
|
|
0
|
|
Blocking L-carnitine synthesis by meldonium prolongs the survival in mice with pancreatic cancer.
(linkinghub.elsevier.com)
|
Sano M
…
Fujishiro M
iScience
2026-08-06
|
#pancreatic cancer
#metabolomics
#metabolism
#therapeutics
#prognosis
|
|
0
|
|
Progress, challenges, and future directions of pancreatic cancer surveillance in high-risk populations.
(nature.com)
|
Poh AR
…
Metz AJ
Communications Medicine
2026-08-03
|
#pancreatic cancer
#surveillance
#early-detection
#biomarker
#hereditary-cancer
|
|
0
|
|
AI-driven discovery and validation of a GIPC1 PDZ domain inhibitor for pancreatic ductal adenocarcinoma.
(linkinghub.elsevier.com)
|
Rachamala HK
…
Mukhopadhyay D
Cell Reports
2026-07-31
|
#drug discovery
#pancreatic cancer
#protein-protein interaction
#chemoresistance
#computational modeling
|
|
0
|
|
Microenvironmental arginine restriction sensitizes pancreatic cancers to polyunsaturated fatty acids by suppression of lipid synthesis.
(elifesciences.org)
|
Jonker PB
…
Muir A
eLife
2026-08-05
|
#metabolism
#pancreatic cancer
#ferroptosis
#microenvironment
#lipid
|